Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Cymeed who wrote (561)	12/18/1997 8:17:00 PM
From: Cymeed	Respond to of 887

How about the chances of DepoCyte approval by Canada, Europe, and other countries ? (eom)

To: Cymeed who wrote (561)	12/18/1997 8:52:00 PM
From: John McCarthy	Respond to of 887

Cymeed - Not being a medical person, I have to walk lightly here. (1) I assume the info in IBD is true and accurate for no other reason then any company lying about such stuff in a news article is looking at a law suit from various parties. BTW - at that time they were NOT looking to peddle more stock. (2) I am guessing the info presented today, was NOT from the same Phase III trial. But a subsequent study. (3) The article in no way hinted at any toxicity problems. Thats why todays news floored me. In addition, has there been an opinion shift with respect to the chemo drug that DC uses in the cancer field between then and now. (4) I believe that the dialogue in today's meeting will, at some time, be available on the FDA website. Not sure when. Right now, I am still getting over the shock of this. So I don't have a good grasp of where we stand. Regards, John